ARRIVENT BIOPHARMA, INC. Shares Outstanding (Cover Page)
ARRIVENT BIOPHARMA, INC. (AVBP) had Shares Outstanding (Cover Page) of 49.31 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 49.31M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 46.57M shares.
- 2026-03-04: Entity Common Stock, Shares Outstanding 44.20M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 41.28M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 49.31M shares 10-Q · filed 2026-08-12 |
| 2026-05-08 | 46.57M shares 10-Q · filed 2026-05-11 |
| 2026-03-04 | 44.20M shares 10-K · filed 2026-03-05 |
| 2025-11-07 | 41.28M shares 10-Q · filed 2025-11-10 |
| 2025-08-08 | 40.57M shares 10-Q · filed 2025-08-11 |
| 2025-05-09 | 34.21M shares 10-Q · filed 2025-05-12 |
| 2025-02-28 | 34.02M shares 10-K · filed 2025-03-03 |
| 2024-11-12 | 33.70M shares 10-Q · filed 2024-11-14 |
| 2024-08-12 | 33.59M shares 10-Q · filed 2024-08-14 |
| 2024-05-07 | 33.49M shares 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |